Technical Analysis for CKPT - Checkpoint Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 1.98 4.76% 0.09
CKPT closed down 7.35 percent on Friday, October 18, 2019, on 1.11 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CKPT trend table...

Date Alert Name Type % Chg
Stochastic Reached Oversold Weakness 4.76%
Wide Bands Range Expansion 4.76%
Oversold Stochastic Weakness 4.76%
20 DMA Resistance Bearish -2.94%
Doji - Bullish? Reversal -2.94%
Outside Day Range Expansion -2.94%
Wide Bands Range Expansion -2.94%
MACD Bullish Signal Line Cross Bullish -2.94%
Narrow Range Bar Range Contraction -2.94%
NR7 Range Contraction -2.94%

Older signals for CKPT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Checkpoint Therapeutics, Inc. is an immuno-oncology biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. The Company is engaged in developing a portfolio of human immuno-oncology targeted antibodies. The portfolio of antibodies that it licensed includes antibodies targeting programmed death-ligand 1 (PD-L1), glucocorticoid-induced Tumor necrosis factor receptor (TNFR) related protein (GITR) and carbonic anhydrase IX (CAIX). It focuses on developing the immuno-oncology and checkpoint inhibitor antibodies. It is developing three oral, small molecules, targeted anti-cancer agents, consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP). Its pipeline of products includes CK-101 and CK-103.
Medicine Immunology Antibodies Immune System Chemotherapy Cancer Immunotherapy Epidermal Growth Factor Receptor Immune Checkpoint Solid Tumor Cancers Checkpoint Inhibitor
Is CKPT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.2
52 Week Low 1.5
Average Volume 60,715
200-Day Moving Average 3.211
50-Day Moving Average 2.5237
20-Day Moving Average 2.1708
10-Day Moving Average 2.001
Average True Range 0.2211
ADX 16.35
+DI 15.1419
-DI 22.6256
Chandelier Exit (Long, 3 ATRs ) 1.9467
Chandelier Exit (Short, 3 ATRs ) 2.4933
Upper Bollinger Band 2.5693
Lower Bollinger Band 1.7723
Percent B (%b) 0.15
BandWidth 36.714575
MACD Line -0.1658
MACD Signal Line -0.1679
MACD Histogram 0.0021
Fundamentals Value
Market Cap 47.95 Million
Num Shares 25.4 Million
EPS -1.10
Price-to-Earnings (P/E) Ratio -1.72
Price-to-Sales 75.20
Price-to-Book 6.30
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.18
Resistance 3 (R3) 2.19 2.10 2.13
Resistance 2 (R2) 2.10 2.03 2.10 2.11
Resistance 1 (R1) 2.00 1.99 1.96 1.99 2.10
Pivot Point 1.91 1.91 1.89 1.91 1.91
Support 1 (S1) 1.81 1.84 1.77 1.80 1.68
Support 2 (S2) 1.72 1.80 1.72 1.67
Support 3 (S3) 1.62 1.72 1.65
Support 4 (S4) 1.61